← Back to Intel
Insider ActivityLUNG
French Glendon E. III, President and CEO at Pulmonx Corp, sold $59K of LUNG
Updated Jun 6, 2026
French Glendon E. III
President and CEO
Pulmonx Corp ·
$LUNG
Transaction Details
| Insider | French Glendon E. III |
|---|---|
| Title | President and CEO |
| Company | Pulmonx Corp |
| Ticker | LUNG |
| Transaction Type | Sale |
| Transaction Date | 2026-06-01 |
| Shares Traded | 38,467 |
| Price Per Share | $1.54 |
| Total Value | $59K |
| Filed Date | 2026-06-03 |
| Accession Number | 0001805624-26-000002 |
Ownership Context
| Shares Owned After Transaction | 1,191,673 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001805624-26-000002
Other Insider Trades — LUNG
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| French Glendon E. III | President and CEO | sold | $21K | 2026-06-02 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer | sold | $3K | 2026-06-01 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer | sold | $6K | 2026-06-01 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer | sold | $9K | 2026-06-01 |
| French Glendon E. III | President and CEO | sold | $6K | 2026-06-01 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | sold | $3K | 2026-06-01 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | sold | $2K | 2026-06-01 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | sold | $4K | 2026-06-01 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | sold | $3K | 2026-06-01 |
| Lehman David Aaron | GENERAL COUNSEL | sold | $6K | 2026-06-01 |
Other Trades by French Glendon E. III
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| LUNG | Pulmonx Corp | sold | $21K | 2026-06-02 |
| LUNG | Pulmonx Corp | sold | $6K | 2026-06-01 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for LUNG — Pulmonx Corp →
Track LUNG insider activity in real time on The Wire →
Get alerts when French Glendon E. III files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 06, 2026 at 07:01 UTC